Area company chases vaccine for niche markets

The vaccine business isn’t a fit for small-thinking companies. One area firm, despite more than $50 million in losses, eyes a significant win in the field.

  • By Elizabeth Djinis
  • | 6:00 a.m. March 5, 2021
  • | 0 Free Articles Remaining!
Courtesy. The main lab for Tampa-based Oragenics is in the Gainesville area.
Courtesy. The main lab for Tampa-based Oragenics is in the Gainesville area.
  • Strategies
  • Share

A Tampa biotechnology company seeks to be a major player in the Super Bowl of the pharmaceutical industry: a COVID-19 vaccine.  

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • December 6, 2025
St. Pete asks residents to design its next creative neighborhood
  • December 5, 2025
Charlotte warehouse developer once jailed over alleged Hamas connection
  • December 5, 2025
Report: 4 markets in region among top 10 nationally in home price cuts
  • December 5, 2025
Frontier Airlines offers new Virginia flight from Tampa International

Sponsored Content